09:00–13:15
Workshop 1: Treatment of eye injuries
more details
13:15–14:50
Session 1: Glaucoma
Przewodniczący sesji: prof. dr hab. n. med. Tomasz Żarnowski
prof. dr hab. n. med. Marek Rękas
prof. Anselm Jünemann
more details
14:50–15:05 Break
15:05–16:20
Session 2: Corneal diseases
Przewodniczący sesji: prof. dr hab. n. med. Edward Wylęgała
dr hab. n. med. Dariusz Dobrowolski
prof. dr hab. n. med. Marek Rękas
more details
16:20–16:35 Break
16:35–17:35
Session 3: Training in Ophthalmology: Insights from EUROCOVCAT Group
Chairmans: prof. dr hab. n. med. Robert Rejdak
prof. Mario Toro
Moderator: dr Faustino Vidal Aroca
more details
17:35–17:55
Roche sponsored lecture: Modulation of the angiopoietin system as a new therapeutic mechanism for macular diseases
prof. dr hab. n. med. Robert Rejdak
more details
17:55–18:05
SCOP Awards Presentation: "Patents of Innovation Leaders"
18:05–19:05
Bayer sponsored session: Around the world — reports on anti-VEGF therapy from various countries
Chairman: prof. dr hab. n. med. Robert Rejdak
dr hab. n. med. Anna Matysik-Woźniak
dr hab. n. med. prof. WIM Małgorzata Figurska
more details
19:05–19:20
Pharmacotherapy in patients with retinal diseases — how to make it in America?
prof. Marco Zarbin
more details
19:20–19:35
Transcomeal Elektrostimulation (TES) in treatment of retinal diseases
prof. Eberhart Zrenner
more details
19:35–19:50
Diagnostics and treatment of vitreous hemorrhage other indications for anti-VEGF therapy
prof. dr hab. n. med. Robert Rejdak
more details
09:00–11:00
Session 4: Cataract
Przewodniczący sesji: prof. dr hab. n. med. Marek Rękas
prof. dr hab. n. med. Robert Rejdak
prof. dr hab. n. med. Dorota Tarnawska
more details
11:00–11:15
Novartis sponsored lecture: Effect of brolucizumab treatment on morphology and visual acuity in patients with wet AMD
dr hab. n. med. Anna Matysik-Woźniak
dr n. med. Emilia Bielecka
dr n. med. Lucyna Baltaziak
dr n. med. Małgorzata Latalska
dr n. med. i n. o zdr. Maksymilian Onyszkiewicz
prof. dr hab. n. med. Robert Rejdak
more details
11:15–11:30
Novartis sponsored lecture: Brolucizumab — quick therapeutic effect and long-term effectiveness. Fifteen-month follow-up
prof. dr hab. n. med. Katarzyna Michalska-Małecka
more details
11:30–11:45
Allergan sponsored lecture: The place of Ozurdex in the treatment of DME, taking into account the drug program B-120
dr hab. n. med. Sławomir Teper
more details
11:45–12:00 Break
12:00–12:20
HOYA sponsored lecture: Optical methods of myopia control for the 21st century
dr n. med. Joanna Przeździecka-Dołyk
more details
12:20–13:50
Session 5: Retina — surgical treatment
Przewodniczący sesji: prof. dr hab. n. med. Jerzy Nawrocki
prof. dr hab. n. med. Katarzyna Nowomiejska
more details
13:50–15:05
Sesja
Chair and Scientific Coordinator: prof. Mario Toro
prof. Giuseppe Guarnaccia
more details
15:05–15:20 Break
15:20–16:50
Session 7: Oculoplasty
Przewodniczący sesji: dr n. med. Rafał Nowak
dr n. med. Izabela Nowak-Gospodarowicz
prof. dr hab. n. med. Marek Rękas
more details
16:50–17:05 Break
17:05–18:35
Session of the Association of Polish Ophthalmology Surgeons (SCOP)
Przewodniczący sesji: prof. dr hab. n. med. Robert Rejdak
prof. dr hab. n. med. Marek Rękas
more details
18:35
Closing of the 6th Ophthalmology Journal online conference "Update in ophthalmology"
Copyrights © 2022 Via Medica